Clinical trial
Detailed Analysis of the Effects of Telmisartan on Renal Perfusion in Patients With Metabolic Syndrome
NCT00452192 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detailed Analysis of the Effects of Telmisartan on Renal Perfusion in Patients With Metabolic Syndrome
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- December 31, 2009
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.